Overall, these results suggest a mild improvement in whole‐body insulin sensitivity in Asb2 MKO mice, although the augmented muscle mass was insufficient to counteract HFD‐induced obesity or glucose intolerance. This evidence concerns the gene ASB2 and Glucose intolerance.